Skip Navigation


Radiation Protection Dosimetry Advance Access originally published online on September 14, 2007
Radiation Protection Dosimetry 2008 128(3):299-308; doi:10.1093/rpd/ncm390
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
128/3/299    most recent
ncm390v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Taylor, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Taylor, D. M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Radiation doses from some [3H]-labelled organic compounds following ingestion

David M. Taylor*

School of Chemistry, Cardiff University, Cardiff, CF10 3TB Wales, UK

* Corresponding author: davtay{at}btinternet.com

Received April 17, 2007, amended June 28, 2007, accepted July 2, 2007

Published information, especially human data, on the biokinetics of 11 compounds labelled with 3H was used to develop simple, cautious compound-specific models and to calculate both tissue absorbed doses and effective doses using the OLINDA computer code. The compounds were [3H]-cortisol, 3{alpha}-Hydroxy-5β-pregnane-11, 20-dione-7-[3H], cyclic 20 trimethylene acetal, [3H]-ifetroban, [3H]-digoxin, 7-[2'-{alpha}-methylphenylethylamino[3H]]theophylline, 7-[2'-{alpha}-methylphenylethylamino]theophylline-[3H], [3H]-amphetamine, [173H]-nicergoline, [3H]-colestipol, [3H]-5(S)-benzamido-4-oxo-6-phenylhexanoyl-l-proline and [6-3H]-thymidine. The calculated effective doses ranged from 6 to 87% of that predicted by the ICRP default model for uncharacterised organic compounds of tritium (OBTM). For all the compounds studied, the retention of 3H in the body was less than that predicted by the OBTM and the route of excretion was found to influence both tissue and effective doses. It is concluded that although the ICRP OBT model may underestimate doses for specific compounds by up to an order of magnitude, it can still be applied with caution for prospective radiological protection purposes, but it should not be applied for the interpretation of bioassay data.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.